Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseases

Patricia Hamminger, Luca Marchetti, Teresa Preglej, René Platzer, Ci Zhu, Anton Kamnev, Ramona Rîca, Valentina Stolz, Lisa Sandner, Marlis Alteneder,

Journal of Autoimmunity · 2021 · 12 citations · 49 references

DOIFull text

Open access

Concepts

Abstract

CD4 + T cell trafficking is a fundamental property of adaptive immunity . In this study, we uncover a novel role for histone deacetylase 1 (HDAC1) in controlling effector CD4 + T cell migration, thereby providing mechanistic insight into why a T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis (EAE). HDAC1-deficient CD4 + T cells downregulated genes associated with leukocyte extravasation. In vitro , HDAC1-deficient CD4 + T cells displayed aberrant morphology and migration on surfaces coated with integrin LFA-1 ligand ICAM-1 and showed an impaired ability to arrest on and to migrate across a monolayer of primary mouse brain microvascular endothelial cells under physiological flow. Moreover, HDAC1 deficiency reduced homing of CD4 + T cells into the intestinal epithelium and lamina propria preventing weight-loss, crypt damage and intestinal inflammation in adoptive CD4 + T cell transfer colitis . This correlated with reduced expression levels of LFA-1 integrin chains CD11a and CD18 as well as of selectin ligands CD43 , CD44 and CD162 on transferred circulating HDAC1-deficient CD4 + T cells. Our data reveal that HDAC1 controls T cell-mediated autoimmunity via the regulation of CD4 + T cell trafficking into the CNS and intestinal tissues.

References

49